The True Cost of Manual Patent Literature Review

Every patent filing decision rests on one question: is this invention new and inventive enough to justify the cost of protecting it? Answering that question before filing is the job of the prior art review — and for most organisations it is still done entirely by hand. The review itself is expensive, but the real cost structure is larger and mostly hidden: queue time, triage bias, inconsistency, and the references nobody found until an examiner did.

This article breaks down where the money and time actually go in manual literature review, why the hidden costs often exceed the visible ones, and how a screening-first workflow changes the math — particularly for university technology transfer offices and organisations filing more than ten applications a year.

The decision the review protects

A pre-filing patentability assessment is not an academic exercise. Filing and prosecuting a European patent commonly runs into tens of thousands of euros over its life once drafting, official fees, examination, validation, and renewal fees are counted. The assessment exists to stop that spend before it starts on inventions that were never patentable.

Seen this way, the review is insurance against a much larger downstream commitment. The question is not whether to assess — it is whether the assessment process itself is fast, consistent, and cheap enough to be applied to every disclosure, rather than only the obvious candidates.

Where the hours actually go

A professional first-pass patentability opinion is commonly quoted in the €2,000–3,000 range and takes days to weeks of calendar time. That price reflects genuinely labour-intensive work, spread across four phases.

None of these phases is optional. A search without synonym coverage misses art that uses different vocabulary. A triage pass that skims misses the one paragraph that anticipates a key feature. An opinion without feature-level mapping cannot be defended when challenged. The cost is high because the work is real.

• —Search formulation: translating a claim into queries with enough terminology and synonym coverage to catch documents that describe the same idea in different words — without revealing the invention in the query itself.
• —Triage: reading and sorting hundreds of candidate documents from patent databases and academic literature down to a shortlist worth detailed analysis.
• —Feature-by-feature comparison: checking each claim feature against each shortlisted document, with locations, to establish what is actually disclosed.
• —Write-up: turning the analysis into a defensible written opinion on novelty and inventive step that a filing decision can rest on.

The hidden costs

The invoice is the visible cost. The hidden costs accrue while disclosures sit in a queue and decisions are made without evidence.

Queue time is the most dangerous. When a review takes weeks, disclosures wait — and in a university setting the inventor may not. A researcher who publishes or presents before the filing decision is made can destroy novelty in most jurisdictions, and grace periods, where they exist at all, are narrow and unreliable. The cost of a slow review can be the entire patent right.

Triage bias follows directly from scarcity. When opinions cost thousands each, only the disclosures that already look promising get assessed. The rest are filed on instinct or dropped without evidence — which means the budget is spent confirming the obvious cases while the surprising ones, in both directions, go unexamined.

Inconsistency compounds the problem. Two reviewers given the same disclosure will formulate different searches, shortlist different documents, and weight features differently. Without a documented, repeatable method, the organisation cannot compare decisions across its portfolio or learn from outcomes.

Finally, there is the missed reference. A document the review did not find does not disappear; it surfaces in examination as a novelty objection, or in opposition as grounds for revocation — after drafting, filing, and prosecution money has been spent. A reference is always cheapest to discover before filing.

The TTO math: why screening-first wins

Consider a university technology transfer office receiving around one hundred invention disclosures a year on a fixed budget. At €2,000–3,000 per professional opinion, assessing all of them is simply not an option; the budget would be exhausted on review before a single application was filed. So the office assesses a fraction and guesses on the rest.

A screening-first workflow restructures this as a funnel. Every disclosure gets a low-cost, evidence-based screen — at a price point around €500 per assessment, screening the entire intake costs a fraction of what a handful of full opinions would. Disclosures that fail the screen are dropped or returned with documented reasons. Disclosures that clear it move forward, and the full attorney opinion is purchased only for that smaller set, where it carries real decision weight.

The result is not that attorneys do less work — it is that their expensive, high-judgement work is concentrated on the disclosures that have already survived an evidence-based filter. The budget shifts from guessing broadly to deciding narrowly, and every disclosure in the portfolio gets at least one documented look.

What a screen must include to be trusted

A cheap screen is only useful if its output can be relied on for a filing decision. That sets a concrete bar: the screen must show its work, the same way a professional opinion does.

A screen that meets this bar can be handed to a patent attorney as a starting point rather than discarded and redone. A screen that does not is just an opinion with a lower price tag.

• —Documented search queries, so the coverage of the search can be inspected and reproduced.
• —A transparent evidence list: every document considered, with identifiers and links, not just the ones cited.
• —Per-feature novelty mapping, with quoted disclosure locations showing exactly where in each document a claim feature is disclosed.
• —Inventive-step reasoning that follows the problem-solution approach under EPC Article 56, not an unstructured impression.
• —Explicit limitations: a clear statement that this is a screening opinion to inform a filing decision, not legal advice.

Where Patentopia fits

This screening-first workflow is what Patentopia sells. An assessment costs €500, runs in minutes rather than weeks, and produces the artefacts listed above: documented searches, a full evidence list, feature-level novelty mapping with disclosure locations, and problem-solution inventive-step analysis — with human-in-the-loop review gates at each stage of the pipeline so a person can inspect and steer the analysis before it proceeds.

It does not replace a patent attorney, and is not meant to. It replaces the guess that currently stands in for an assessment on every disclosure that never got one.